Review of current and investigational pharmacologic agents for acute heart failure syndromes.
about
Micro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assayCardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal modelCardiovascular effects in rats following exposure to a receptor tyrosine kinase inhibitorHyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy.Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.Positive inotropes in heart failure: a review articleOverview of emerging pharmacologic agents for acute heart failure syndromes.Specific mediator inhibition by the NO donors SNP and NCX 2057 in the peripheral lung: implications for allergen-induced bronchoconstriction.Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.Heart failure in hypertension: prevention and treatment.Acute decompensated heart failure: evolving literature and implications for future practice.PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.Acute pulmonary oedema: clinical characteristics, prognostic factors, and in-hospital management.Chronic istaroxime improves cardiac function and heart rate variability in cardiomyopathic hamsters.New arylsparteine derivatives as positive inotropic drugs.Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice.
P2860
Q27341916-8CB49C6E-6491-4880-A3FF-1C79C672FB3EQ28243737-5376F1EB-71EA-4571-9668-E3EA8A98B404Q28276103-6B9D07B3-528F-4C87-92D7-B0B8E988F746Q30432267-08B03662-A897-4666-B948-E10CD40FF5CCQ33552229-303271B1-FA13-42EA-8AF2-9318AB495C22Q33721181-943C5402-1451-435A-A780-20606928B44EQ36982705-F05D111B-1002-436E-94C7-BC29CE60540AQ37086309-1EDC3325-5C9C-4E8E-A2BA-45FC6B882D4AQ37227654-7F8AB4F4-8379-414B-B978-63E0FF7574A7Q38009708-6782578C-B0D3-46E1-92CD-8E2BB33AED80Q38022713-53A101CF-026D-4A38-9228-21D59AF486C5Q38161451-2B402976-8767-487E-82BA-DB52E5C4C56DQ42325938-0B552948-8962-4926-A311-7A81523AF81BQ42908864-3DA663C8-EDD6-4DA0-A489-FEB8F70079ADQ51769776-73C9A26A-4294-422F-AC8F-CFB5B6B15701Q53540568-5B46BB30-0DD0-405C-BC57-767ED1CD24CAQ54572183-5A29A10D-FBF2-4580-A4AD-44FFFE5809FF
P2860
Review of current and investigational pharmacologic agents for acute heart failure syndromes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Review of current and investig ...... acute heart failure syndromes.
@ast
Review of current and investig ...... acute heart failure syndromes.
@en
type
label
Review of current and investig ...... acute heart failure syndromes.
@ast
Review of current and investig ...... acute heart failure syndromes.
@en
prefLabel
Review of current and investig ...... acute heart failure syndromes.
@ast
Review of current and investig ...... acute heart failure syndromes.
@en
P2093
P50
P1476
Review of current and investig ...... acute heart failure syndromes.
@en
P2093
David D Shin
Filippo Brandimarte
Hani N Sabbah
Leonardo De Luca
P304
P356
10.1016/J.AMJCARD.2006.11.025
P407
P577
2006-11-27T00:00:00Z